Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
EASIX-1year and late mortality after allogeneic stem cell transplantation
Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
Statin‐based endothelial prophylaxis and outcome after allogeneic stem cell transplantation
Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation
EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation
Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD
Easix before Conditioning Therapy Predicts Sepsis after Allogeneic Stem Cell Transplantation
Vitamin D Deficiency and Outcome of COVID-19 Patients
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel
CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT
EASIX and mortality after allogeneic stem cell transplantation
EASIX for prediction of survival in lower-risk myelodysplastic syndromes
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party
Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study
Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation
Outcome of Allogeneic Haematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms-Unclassifiable: A Retrospective Study By the Chronic Malignancies Working Party of EBMT
PF545 EASIX FOR PREDICTION OF SURVIVAL IN LOWER RISK MYELODYSPLASTIC SYNDROMES
High Pre-Transplant Free Interleukin-18 Is Associated with Poor Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction
Easix for Prediction of Survival in Myelodysplastic Syndromes
The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients
Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation
Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands
Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis